UK science adviser: other vaccine trials also likely to be paused

Chief Scientific Adviser Sir Patrick Vallance speaks during a virtual news conference on the ongoing situation with the coronavirus disease (COVID-19), at Downing Street, London, Britain September 9, 2020. Stefan Rousseau/Pool via REUTERS

LONDON (Reuters) - Other COVID-19 vaccine trials are likely to be paused at some point the British government’s Chief Scientific Adviser Patrick Vallance, said, describing a pause in the trial of an AstraZeneca [AZN.L] vaccine as “not good” but a sensible step.

“I think you should expect in some of the other trials that you will see situations where things are paused and then restarted,” Vallance told a news conference.

“We need to make sure with these vaccines that they work, they work well enough, and they are safe,” he added.

Reporting by William James; editing by Stephen Addison